PatternsRadar
Sign in

MEDPLUSMedplus Health Services Limited

NSE
Full chart
651.45INR+7.05 (+1.09%)Close · 6 Oct 2026
21 Jul 2026Last results
Consumer ServicesSector
RetailingIndustry
₹7,826 CrMarket cap
37.2P/E (TTM)
56.1%Delivery

Filings & corporate actions

18 results filed
CSV
Next results · Q2 FY27
Expected 31 Oct 2026 – 13 Nov 2026
Estimate: filed 31–44 days after quarter end, last 3 times
2026
  • 21 JulresultsResults · Q1 FY27 · consolidated and standalone-12.8%NSE
  • 18 JulshareholdingShareholding · 30 Jun 20260.0%NSE
  • 20 MayresultsResults · Q4 FY26 · consolidated and standalone+4.7%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+1.0%NSE
  • 30 JanresultsResults · Q3 FY26 · consolidated and standalone+2.9%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-1.7%NSE

Reaction to results · all yearsrose on day 0 in 11 of 18 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2721 Jul 2026-12.8%-9.1%-18.2%18.7×
Q4 FY2620 May 2026+4.7%-1.7%-7.3%18.8×
Q3 FY2630 Jan 2026+2.9%+8.8%+6.1%1.2×
Q2 FY2631 Oct 2025+7.5%-0.4%+5.0%100.0×
Q1 FY262 Aug 2025+0.5%-9.2%-7.9%2.1×
Q4 FY2527 May 2025+1.7%-4.2%-6.9%4.9×
Q3 FY2531 Jan 2025+8.8%+10.1%+0.1%3.6×
Q2 FY2513 Nov 2024+1.2%+9.9%+26.6%9.8×
Q1 FY252 Aug 2024-1.0%-4.3%+3.8%2.7×
Q4 FY2429 May 2024-1.9%-0.8%-2.6%4.9×
Q3 FY242 Feb 2024-1.1%-9.2%+0.8%1.4×
Q1 FY247 Aug 2023-4.4%-5.0%-13.9%1.6×
Q4 FY2326 May 2023+17.9%+17.8%+13.5%79.5×
Q3 FY236 Feb 2023+2.4%+3.1%+10.2%0.5×
Q2 FY2311 Nov 2022+6.1%+9.5%+26.3%42.2×
Q1 FY2311 Aug 2022+0.9%+0.4%+0.2%0.9×
Q4 FY2230 May 2022-0.1%-4.3%-11.7%6.2×
Q3 FY2215 Feb 2022-1.3%-11.4%-6.9%0.6×
Average+1.8%-0.0%+1.0%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+21.8%
Profit YoY-21.7%
Interest cost YoY+20.0%
Revenue QoQ+0.8%
Profit QoQ-48.2%
CAGR2Y3Y4Y5Y6Y7Y
Revenue—+14.2%————
Profit—+61.3%————

Key data

CSV
Open649.90
Day range642.10 – 655.55
52-week range640.10 – 1,022.20
From 52w high-36.3%
RSI (14)42.0
ATR (14)14.39
Volume1.21L
Avg volume (20D)94.8K
Rel volume1.28×
Volatility (1Y)30.2%
Turnover₹7.9Cr
SMA 50 / 200672.08 / 799.66

Delivery percentage

Latest · 6 Oct 202656.1%
20-day avg60.7%
1-year avg58.1%
Percentile (own history)56th
Range8.1–97.7%
Sessions1,183

Over the last 20 sessions MEDPLUS settled 60.7% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 58.1%, so recent sessions are running 2.6 points higher than usual. The latest session ranks higher than 56% of the 1,183 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmacy Retail
PeersSSRETAILETERNALMEESHOLENSKARTSWIGGYTRENT

Performance returns

CSV
1D1W1M3M6M1Y
Price+1.09%-0.24%-1.39%-20.23%-22.08%-17.21%

Valuation

CSV
Market cap₹7,826 Cr
P/E (TTM)37.2
EPS (TTM)17.52
Shares outstanding12.01Cr
Listed23 Dec 2021

Ownership

CSV
Promoter40.19%
Promoter Δ QoQ-0.03 pp
Public59.77%
FII14.38%
DII29.95%
Pledged60.74%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)1,679.31,806.11,864.41,879.6
YoY chg+6.5%+15.7%+23.5%+21.8%
Net profit (₹ Cr)55.557.864.033.2
YoY chg+43.4%+26.0%+24.7%-21.7%
Net margin3.3%3.2%3.4%1.8%
EPS4.624.815.332.76

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 40.19% · public 59.77%
22 Dec 2021: promoter 40.43%31 Dec 2021: promoter 40.43%31 Mar 2022: promoter 40.43%30 Jun 2022: promoter 40.43%30 Sept 2022: promoter 40.43%31 Dec 2022: promoter 40.43%31 Mar 2023: promoter 40.43%30 Jun 2023: promoter 40.43%30 Sept 2023: promoter 40.41%31 Dec 2023: promoter 39.00%31 Mar 2024: promoter 40.39%30 Jun 2024: promoter 40.39%30 Sept 2024: promoter 40.39%31 Dec 2024: promoter 40.39%31 Mar 2025: promoter 40.34%30 Jun 2025: promoter 40.32%30 Sept 2025: promoter 40.29%31 Dec 2025: promoter 40.29%31 Mar 2026: promoter 40.22%30 Jun 2026: promoter 40.19%
2021-122026-06
  • Promoter
  • Public and others
Promoter
40.19%
Public
59.77%
Promoter change
-0.03 pp
Filed
18 Jul 2026
FII
14.38%
DII
29.95%
Promoter pledged
60.74%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q1 FY24Q3 FY24Q4 FY24AQ1 FY25AQ2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations1,284.31,441.51,490.51,488.81,576.21,561.41,509.61,542.61,679.31,806.11,864.41,879.6
Other income9.49.810.58.711.612.515.815.017.518.220.619.8
Total income1,293.71,451.31,501.01,497.51,587.81,574.01,525.41,557.71,696.81,824.41,885.01,899.4
Total expenses1,288.61,431.31,469.01,479.81,540.01,517.41,464.31,504.91,627.91,751.11,804.61,857.5
└ Finance costs23.324.525.124.725.126.026.827.428.830.833.533.3
└ Depreciation52.457.159.260.063.162.564.265.668.672.775.977.9
Profit before tax5.120.032.017.847.856.661.152.868.973.380.341.9
Tax expense1.36.3(1.6)3.49.110.79.810.413.415.516.48.7
Net profit3.813.733.614.338.745.951.342.355.557.864.033.2
EPS0.321.152.811.203.243.844.323.544.634.825.332.76
Net margin0.29%0.95%2.25%0.96%2.46%2.94%3.40%2.74%3.31%3.20%3.43%1.76%
PBT margin0.39%1.38%2.15%1.19%3.03%3.62%4.05%3.42%4.10%4.06%4.31%2.23%
Tax rate25.46%31.34%-4.93%19.36%19.01%18.96%16.03%19.75%19.49%21.15%20.37%20.80%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 21 Jul 2026.

MEDPLUS at a glance

  • MEDPLUS closed at ₹651.45 on 6 Oct 2026, +1.09% on the day, -17.2% over one year, 36.3% below its 52-week high of ₹1,022.2.
  • Delivery was 56.1% of traded quantity on 6 Oct 2026, the 56th percentile of its own 1,183 sessions with a reading (20-session average 60.7%, 1-year average 58.1%).
  • Market capitalisation is ₹7,826 crore at a trailing P/E of 37.2 (trailing EPS ₹17.52).
  • Q1 FY27 results (consolidated, filed 21 Jul 2026): revenue ₹1,880 crore (+21.8% year on year), net profit ₹33 crore (-21.7%); the price moved -12.8% on the first session after.
  • Promoters held 40.19% at 30 Jun 2026, down 0.03 percentage points on the previous filing, with 60.74% of promoter shares pledged.
  • Q2 FY27 results are expected between 31 Oct 2026 and 13 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorConsumer Discretionary
Basic industryPharmacy Retail
ISININE804L01022
SeriesEQ
Listed23 Dec 2021
History from23 Dec 2021
Sessions1,186

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Retailing

CSV

All Retailing stocks on the NSEAll Consumer Services stocks on the NSE